Figures & data
Table 1. Outcome, strategy in referral and treatment of patients with IE and cancer.
Martínez-Sellés M, Muñoz P, Arnáiz A, et al. Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. Int J Cardiol. 2014;175(1):133–137. Ohara T, Nakatani S, Kokubo Y, et al. Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol. 2013;167(6):2688–2694. Athan E, Chu VH, Tattevin P, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727–1735. Olmos C, Vilacosta I, Habib G, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017;103(18):1435–1442. Mesa del Castillo-Paya C, Rodriguez-Esteban M, Quijada-Fumero A, et al. Infective endocarditis in patients with oncological diseases. Enferm Infecc Microbiol Clin. 2018;36:72–77. Kanafani ZA, Kanj SS, Cabell CH, et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. Eur J Clin Microbiol Infect Dis. 2010;29(10):1203–1210. Sambola A, Fernández-Hidalgo N, Almirante B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol. 2010;106(1):92–98. Carugati M, Petti CA, Arnold C, et al. Antistaphylococcal β-lactams versus vancomycin for treatment of infective endocarditis due to methicillin-susceptible coagulase-negative staphylococci: a prospective cohort study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother. 2016;60(10):6341–6349. Fernandez-Cruz A, Munoz P, Sandoval C, Farinas C, et al. Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm? Medicine. 2017;96(38):e7913. Mohkles MM, Ciampichett I, van Domburg R, et al. Infective endocarditis in a tertiary referral hospital: long-term follow up. J Heart Valve Dis. 2012;21(1):118–124. Thuny F, Giorgi R, Habachi R, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J. 2012;164(1):94–101. Chirouze C, Athan E, Alla F, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2013;19(12):1140–1147. Lu KJ, Kearney LG, Ord M, et al. Age adjusted Charlson co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis. Int J Cardiol. 2013;168(6):5243–5248. Korem M, Israel S, Gilon D, et al. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Int Med. 2014;25(6):550–555. Delahaye F, Chu VH, Altclas J, et al. One-year outcome following biological ormechanical valve replacement for infective endocarditis. Int J Cardiol. 2015;178:117–123. Chirouze C, Alla F, Fowler VG, Jr, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the international collaboration of endocarditis–prospective cohort study. Clin Infect Dis. 2015;60(5):741–749.